Monthly Archives: February 2011

Vivitrol in Opiate Addiction Treatment

viviVivitrol® is a new product of Alkermes (a U.S. based pharmaceutical company who specialize in disease management medications). Vivitrol received FDA approval in October 2010 for use in the prevention of opioid relapse following opioid detoxification. It is an extended release formulation of naltrexone designed to be administered through a once monthly IM (intramuscular) injection.

The medication is a non-addictive, opioid antagonist that blocks the effects of opioids, and thus discourages opioid misuse since no subjective euphoria is experienced. Opioid addicted individuals are often at high risk for relapse following opioid detox, and intensive support is very helpful in assisting these individuals with establishing a comfortable, lasting sobriety following successful opioid detox.

Vivitrol must be administered by a healthcare professional, and recipients should not have active liver disease complications since naltrexone (the active ingredient in Vivitrol) is contraindicated for those with acute hepatitis. Like any medication-assisted intervention, Vivitrol should be used in conjunction with ongoing behavioral health counseling in order to maximize a client's chance of successful long term recovery through skill development and lifestyle change.

The medication is not inexpensive (obviously a patented medication with no available generic equivalent). But considering its potential benefit to those in early recovery, it may be a worthwhile short-term investment in the first 30 to 90 days when recovering persons are at highest risk for opioid relapse. An obvious benefit of Vivitrol is that the patient does not have to take a daily pill, so either accidental or purposeful missed doses are not a concern.

Opioid Addiction the Unwanted Companion

methadone91Many decent people have wondered how they ended up in the middle of an opioid addiction. Looking back, they retrace their past wishing they could undo some steps along the way. Facing opioid dependency becomes its own exhausting daily routine. Thinking about the past hurts, and looking forward brings worry. So one sits in the moment feeling a certain pain that just won't go away.

As addiction and its related problems fester, and infiltrate the important aspects of one's life, worry and anxiety become familiar feelings. These painful feelings will deepen addiction for some people as they become paralyzed with indecision and regret. Many fall further into their opioid dependency as they numb the pain with more drug use. This, of course, is not the answer.

If change is to occur, there are decisions which the addicted person must make. Addiction can be a devastating illness, yes. But addiction is also treatable, and this must never be forgotten. The progressive nature of opiate addiction means that the addiction worsens over time (progresses) unless the addicted individual does something to arrest the disease progression.

This is where treatment enters the picture. Many lives have been saved, and futures restored, by simply making the decision to get help. Getting help means accepting responsibility for choosing, and then staying the course. Methadone treatment programs, and other treatment options, are available. Treatment, and recovery, are not easy. But they are definitely worth the effort. Recovery brings light, opens doors, and reconnects one to the things that make life worthwhile again. This is the promise of recovery.

Seeking treatment may require some patience. Do not get discouraged. Sometimes, asking someone to help you find treatment resources can go a long way. Remember, you are worth it. And things can change. Methadone, suboxone, detox, inpatient rehab, and other treatment interventions are available. Step onto a new path.

Benzodiazepine and Methadone Considerations

safetyAnxiolytics are a frequently prescribed classification of drugs that are utilized to reduce anxiety and which may provide some anticonvulsant benefits for those at risk of seizure. The most common of this class are benzodiazepines such as Xanax, Ativan, Valium, Klonopin, or Librium. These medications have helped many people who suffer with generalized anxiety or panic disorder.

However, there is some consensus that benzodiazepines are over-prescribed. They are typically provided on a short-term basis only since tolerance & dependency can develop with prolonged use. Of particular concern to opioid treatment providers is the potential for fatal overdose when "benz" medications are taken in conjunction with methadone.

This is a delicate issue in that many methadone clinics have adopted a policy that disallows any use of benzodiazepines while a client is receiving methadone. This decision came about several years ago, as a safety measure, when a number of client deaths occurred tied specifically to benzodiazepine and methadone use combined.

It must be said that there are methadone patients who have received & taken benzodiazepine medication responsibly and experienced no problem. But the medical and addiction treatment community have recognized a significant risk associated with the mixture of these two potent medications. Ultimately, a program's physician is the one who bears responsibility for which medications can be safely administered. When benzodiazepines are determined to be "too risky", this can leave a methadone patient feeling defenseless & concerned about their ability to manage their chronic anxiety. No doubt, unmanaged co-occurring disorders (and uncomfortable associated symptoms) can put clients at increased risk of drug relapse.

It is very important that treatment providers (opioid programs) give their clients ample support & alternative options for coping with their anxiety. There are non-addictive medications-of-choice for treating anxiety such as Buspar, and also a variety of cognitive-behavioral approaches that help clients learn to moderate their anxiety symptoms using newly developed skills.

In the end, opioid program clients put their trust in the expertise of the clinic physicians & staff who aim to help them. Sometimes, there is no perfect answer. And clinic staff must base a treatment decision on maximum client safety as well as factoring in liability concerns that could even jeopardize the clinic's existence. Benzodiazepines will remain a high priority topic for some time to come. They too, like methadone, are helpful medications. They too, like methadone, must be closely monitored and used appropriately.

Methadone Clinic Jobs

client78Methadone.US aims to serve a number of different purposes, including: educating the public on medication-assisted treatment, helping people to find methadone clinics & buprenorphine providers, and encouraging opioid dependent persons to commit to the recovery process as soon as possible.

You may have noticed that in addition to the above, Methadone.US has incorporated an employment section to aid professionals in locating job positions in the opioid treatment field. The job postings are updated daily, and highlight employment opportunities across the entire United States.

Our site is growing. Presently, contact information for methadone clinics and buprenorphine providers is being added daily to the Methadone.US database. More specialty sections and physician article feeds are soon to come such that site visitors can find new information & perspectives with each visit to the site.

It is estimated that over 2 million people in America are struggling with an opiate abuse or dependency issue. This number does not include their family members, their employers, the legal system, and beyond. All totaled, the presence & impact of opioid addiction on society is quite large. Hopefully, Methadone.US will help to make a difference … one person at a time. Thanks for visiting the site today. Your feedback is always welcomed on how we may improve.